Literature DB >> 10624366

Underreporting of adverse drug reactions: attitudes of Irish doctors.

D Williams1, J Feely.   

Abstract

Despite the fundamental importance of reporting of suspected adverse drug reactions, less than 10 per cent of serious adverse drug reactions are reported. To further enhance our understanding of doctors' knowledge and attitudes to the current Adverse Drug Reaction (ADR) reporting scheme we surveyed 158 doctors, including some 106 general practitioners and 23 hospital-based doctors. The response rate was 39.5 per cent. The majority had experience of reporting an ADR. Seriousness of the ADR appears to be the most important reason for reporting. Uncertainty that the adverse drug reaction was definitely caused by the medicine, that the adverse drug reaction was too trivial to report or that it was too well known a reaction to report are common reasons for not reporting. Of concern 84 per cent of doctors are unaware of the criteria of the National Drug Regulatory Agency indicating the need for additional education and information in this regard. We also found considerable disagreements in doctors' understanding of the meaning of common, occasional, rare, or very rare as applied to ADRs.

Entities:  

Mesh:

Year:  1999        PMID: 10624366     DOI: 10.1007/bf02944353

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  6 in total

1.  Stimulating reporting of adverse drug reactions by using a fee.

Authors:  J Feely; S Moriarty; P O'Connor
Journal:  BMJ       Date:  1990-01-06

2.  Making medicines safer--the need for an independent drug safety board.

Authors:  A J Wood; C M Stein; R Woosley
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

Review 3.  Adverse drug reactions.

Authors:  M Pirmohamed; A M Breckenridge; N R Kitteringham; B K Park
Journal:  BMJ       Date:  1998-04-25

4.  Reporting of adverse drug reactions by hospital doctors and the response to intervention.

Authors:  P McGettigan; J Golden; R M Conroy; N Arthur; J Feely
Journal:  Br J Clin Pharmacol       Date:  1997-07       Impact factor: 4.335

5.  Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.

Authors:  K J Belton; S C Lewis; S Payne; M D Rawlins; S M Wood
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

6.  The spontaneous reporting of adverse drug reactions by nurses.

Authors:  M Hall; P McCormack; N Arthurs; J Feely
Journal:  Br J Clin Pharmacol       Date:  1995-08       Impact factor: 4.335

  6 in total
  29 in total

Review 1.  What can consumer adverse drug reaction reporting add to existing health professional-based systems? Focus on the developing world.

Authors:  Rohini B M Fernandopulle; Krisantha Weerasuriya
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Semi-intensive versus intensive monitoring of adverse drug reactions in a hospital.

Authors:  Slobodan M Jankovic; Dragan R Milovanovic; Dragana Nedovic; Sladjana Petrovic
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; J J Gestal-Otero
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Data mining in pharmacovigilance: lessons from phantom ships.

Authors:  Manfred Hauben; Lester Reich; Eugène P Van Puijenbroek; Charles M Gerrits; Vaishali K Patadia
Journal:  Eur J Clin Pharmacol       Date:  2006-08-03       Impact factor: 2.953

5.  Adverse-drug-reaction related admissions to a hospital in Scotland.

Authors:  Yvonne Hopf; Margaret Watson; David Williams
Journal:  Pharm World Sci       Date:  2008-07-25

Review 6.  Determinants of under-reporting of adverse drug reactions: a systematic review.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China.

Authors:  Jun Liu; Zhongliang Zhou; Shimin Yang; Bianling Feng; Jun Zhao; Hua Liu; Haiyan Huang; Yu Fang
Journal:  Int J Clin Pharm       Date:  2015-04-02

8.  Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.

Authors:  Saad Abdulrahman Hussain; Ashwaq Nagemeldeen Abbas; Shah-Zanan Alaa Habeeb; Athraa Kareem Abd-Ali; Zainab Saad Abdulrahman
Journal:  Int J Clin Pharm       Date:  2019-06-25

9.  Community pharmacists' knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia.

Authors:  Tahir M Khan
Journal:  Ther Adv Drug Saf       Date:  2013-04

10.  Pharmacovigilance: empowering healthcare professionals and patients.

Authors:  Stephane Steurbaut; Yolande Hanssens
Journal:  Int J Clin Pharm       Date:  2014-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.